Accelsiors CRO

Accelsiors, established in 2002, is a full-service Contract Research Organization (CRO) dedicated to supporting the biopharmaceutical industry throughout all phases of clinical drug development. With a global presence spanning over 40 countries and 27 offices, we are strategically positioned to meet diverse clinical trial needs worldwide. Our operations reach five continents, utilising both office-based staff and regional experts to ensure local expertise and responsiveness. Headquartered in Switzerland, Accelsiors benefits from being at the heart of Europe’s biopharmaceutical hub. This enables us to deliver consistent, high-quality results while adhering to global regulatory standards. Our mature and innovative processes are designed to manage trials of varying complexity, ensuring timely and budget-conscious outcomes. Accelsiors has a proven track record in supporting product development across a wide range of therapeutic areas, including Neuroendocrinology, Oncology, Respiratory, Hepatology, and Autoimmune diseases, with a particular emphasis on Orphan Indications. We are the leaders in Biosimilars development programs partnering with a broad range of clients from emerging biotech to big pharma. With a client-focused approach, we tailor our services to meet unique project needs, ensuring a smooth pathway from preclinical stages through to post-marketing support. This makes us a trusted partner in bringing innovative therapies to market efficiently, accelerating the journey of innovative therapies to patients worldwide.